Respiratory Illness News and Research

RSS

Fat-filled immune cells found in victims of vaping illness

The frightening outbreak of mysterious respiratory illness linked to the use of e-cigarettes, or vaping, have shaken the medical community.

9 Sep 2019

Vaping-related respiratory illness characterized by lipid-laden macrophages in the lungs

Doctors have identified a previously unrecognized characteristic of the vaping-related respiratory illness that has been emerging in clusters across the U.S. in recent months.

8 Sep 2019

Statement on FDA and CDC collaboration to investigate respiratory illnesses related to e-cigarette use

Both the U.S. Food and Drug Administration and the U.S. Centers for Disease Control and Prevention are working tirelessly to investigate the distressing incidents of severe respiratory disease associated with use of e-cigarette products.

30 Aug 2019

Years ago, this doctor linked a mysterious lung disease to vaping

Dr. John E. Parker was working at a West Virginia hospital in 2015 when a 31-year-old female patient was admitted with acute respiratory problems.

23 Aug 2019

Mysterious lung disease linked to vaping spreads across 14 US states

The CDC is investigating a series of cases of mysterious, severe lung disease. The cause is not known, but every patient uses an e-cigarette.

21 Aug 2019

Study provides evidence that enterovirus may be a factor in acute flaccid myelitis

A new study analyzing samples from patients with and without acute flaccid myelitis provides additional evidence for an association between the rare but often serious condition that causes muscle weakness and paralysis, and infection with non-polio enteroviruses.

13 Aug 2019

NIH contract awarded to UAB for acute flaccid myelitis natural history study

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded the University of Alabama at Birmingham approximately $10 million over 5 years to study acute flaccid myelitis, a rare but serious condition which causes muscle weakness and paralysis.

23 Jul 2019

Many healthcare workers often care for patients while sick, study finds

Large numbers of healthcare workers risk transmitting respiratory viruses to patients and co-workers by attending work even when they have symptoms, according to a study published today in Infection Control & Hospital Epidemiology, the journal for the Society for Healthcare Epidemiology of America.

18 Jun 2019

Replacing a small amount of red meat with healthier foods may improve life expectancy

A new large-scale review of data on red meat consumption and mortality suggests that increasing intake of red and processed meats reduces life expectancy.

13 Jun 2019

14 years of investigations reveal how Nipah virus spreads from person to person

The deadly Nipah virus, which is carried by bats and occasionally infects people, is more likely to be transmitted from person to person when the infected patient is older, male and/or has breathing difficulties, according to a study co-led by scientists at the Johns Hopkins Bloomberg School of Public Health.

From Johns Hopkins Medicine 9 May 2019

Air pollution increases risk for respiratory hospitalization among childhood cancer survivors

Poor air quality days significantly increase the risk of hospitalizations for respiratory issues in young survivors of cancer, according to a study conducted by researchers at Huntsman Cancer Institute at the University of Utah and published in the International Journal of Environmental Research and Public Health.

24 Apr 2019

Researchers develop novel recombinant vaccine against Nipah virus

Nipah virus is a type of RNA virus transmitted from animals to humans. The infection causes severe respiratory illness and symptoms including cough, headache and fever, which can progress into encephalitis, seizure and coma.

15 Apr 2019

Infants with bronchiolitis are at increased risk of hospitalization for asthma in preschool years

Infants who are admitted to hospital with the common infection bronchiolitis are at increased risk of further emergency hospital admissions for asthma, wheezing and respiratory illness in the first five years of their life.

6 Mar 2019

Human 'common cold' virus continues to spread in wild chimpanzees

Less than two years after the first report of wild chimpanzees in Uganda dying as a result of a human "common cold" virus, a new study has identified two other respiratory viruses of human origin in chimpanzee groups in the same forest.

22 Jan 2019

Rising air pollution linked with increased ER visits for breathing problems

As levels of ozone and fine particulate pollution (PM2.5) rise, more patients end up in the ER with breathing problems, according to the largest U.S. study of air pollution and respiratory emergency room visits of patients of all ages.

18 Jan 2019

Extensive scientific evidence available on air pollution's harms to children

A new study led by researchers at the Columbia Center for Children's Environmental Health organizes the available scientific evidence on the effects of air pollution on children's health.

20 Dec 2018

Choking deaths pose serious threat to the wellbeing of people with disability

Speech Pathology Australia welcomes the Victorian Disability Services Commissioner’s report, “A review of disability service provision to people who have died 2017-18”, tabled in the Victorian Parliament yesterday, 19 December.

20 Dec 2018

Sema4, Mount Sinai, Sanofi announce launch of new collaborative asthma study

Sema4, a patient-centered predictive health company, and the Mount Sinai Health System today announced the launch of a five-year collaborative study with Sanofi designed to provide new insights into the biological mechanisms and other factors implicated in asthma.

4 Dec 2018

FDA approves new antiviral flu treatment

Today, the U.S. Food and Drug Administration approved Xofluza (baloxavir marboxil) for the treatment of acute uncomplicated influenza (flu) in patients 12 years of age and older who have been symptomatic for no more than 48 hours.

24 Oct 2018

Vaxart to present new data from Phase 2 Challenge Study of H1 influenza oral tablet vaccine

Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced it will present new data from the Phase 2 Challenge Study of its H1 influenza oral tablet vaccine at IDWeek 2018 in San Francisco on Saturday, October 6, 2018.

4 Oct 2018